CMA statement on Supreme Court's order granting stay in medication abortion case Donaldo Hernandez, M.D., the president of the California Medical Association (CMA), issued the following statement in response to the Supreme Court order granting a stay in the lawsuit against the U.S. Food and Drug Administration (FDA) over its approval of mifepristone. “The U.S. Supreme Court’s order today to stay the lower court rulings is great news, as it means mifepristone will remain available in the interim for the lives and welfare of millions of people who might need this drug that has been FDA-approved as safe and effective for 23 years. “As ... April 24, 2023 CMA, Drug Prescribing/Dispensing, Healthcare, legislation, Patient Care FDA, Reproductive RIghts 0 0 Comment Read More »
